Andere Sprachen Gland Pharma Limited

Aktien

A2QG5F

INE068V01023

GLAND

Markt geschlossen - NSE India S.E. Andere Börsenplätze 13:43:48 03.05.2024			% 5 Tage	% 1. Jan.
1 686 ^INR	-2,08 %		-2,42 %	-12,37 %

29.04.	Gland Pharma ernennt COO	MT
29.04.	Gland Pharma Limited genehmigt die Ernennung von Herrn Satnam Singh Loomba zum Chief Operating Officer mit Wirkung vom 1. Mai 2024	CI

Andere Sprachen

Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!

100% kostenlose Registrierung

Gland Pharma Names COO	29.04.
Gland Pharma Limited Approves Appointment of Mr. Satnam Singh Loomba as Chief Operating Officer, Effective May 1 ,2024	29.04.
Gland Pharma Gets US FDA's Final Approval for Generic Drug for Luteinizing Hormone Surges	29.04.
Nicomac Machinery and RP Advisory Services Reportedly Likely to Sell 4.4% Stake in Gland Pharma via Block Deals	08.04.
Gland Pharma Gets US FDA Approval for Eribulin Mesylate Injection	08.04.
Gland Pharma Limited Receives Approval from the United States Food and Drug Administration for Eribulin Mesylate Injection 0.5 Mg/ML Single Dose Vial	06.04.
Gland Pharma COO, Chief Technical Officer Step Down	25.03.
Gland Pharma Limited Announces Change in Management	25.03.
Gland Pharma Names New President of Phixen Subsidiary	27.02.
Gland Pharma's Consolidated Profit Drops in Fiscal Q3	15.02.
Gland Pharma Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	14.02.
Indian shares set to open lower as hot US inflation spurs rate worries	14.02.
Gland Pharma Gets Establishment Inspection Report from US FDA for Pashamylaram Unit	24.11.
32,656,565 Equity Shares of Gland Pharma Limited are subject to a Lock-Up Agreement Ending on 18-NOV-2023.	18.11.
Gland Pharma Gets US FDA's Tentative Approval for Generic Hypotension Drug	15.11.
Gland Pharma Limited Receives Tentative Approval for Angiotensin II Injection	15.11.
Abbott India's Q2 profit climbs on strong sales	09.11.
Gland Pharma Gets US FDA's EIR Report Closing Inspection of Visakhapatnam, India Unit	08.11.
Indian shares set to open marginally higher	07.11.
India's Gland Pharma misses Q2 profit view on higher expenses	06.11.

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen Gland Pharma Limited

Aktien

A2QG5F

INE068V01023

GLAND

Andere Sprachen

Filter